DOJ, DDB review RA 9165 on drug policies

The Department of Justice (DOJ) and the Dangerous Drugs Board (DDB) have initiated an executive review of Republic Act 9165 or the Comprehensive Dangerous Drugs Act of 2002, as directed by President Marcos.

The review focuses on enforcement measures and rehabilitation programs for drug offenders, aiming to adopt a 'whole-of-government' approach that includes social services and multi-faceted interventions.

Undersecretary Jesse Hermogenes T. Andres of the DOJ stated that the proposed amendments will be evidence-based and aligned with international standards.

Stakeholders such as non-government organizations, civil society groups, and international partners like the UNODC are participating in the review process to ensure a consultative approach.

The government is seeking input from subject matter experts including human rights and health advocates to inform policy recommendations.

This review follows the 1st Drug Policy and Law Reform Summit held last July 2024, where stakeholders provided valuable insights.